Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2193]
News [4497]
Articles [112]
Editorials [23]
Conferences [171]
elearning [18]
Clinical characteristics and prognostic factors of plasmablastic lymphoma...
Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients ( Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France )
11 Jun 2016
Recent developments in targeted therapies
Dr Stephen Nimer - University of Miami, Miami, USA
Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016
MyPathway guidance of targeted therapy based on molecular profiles
Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
6 Jun 2016
Patient engagement in The Metastatic Breast Cancer Project
Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA
Patient engagement in The Metastatic Breast Cancer Project ( Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA )
4 Jun 2016
Editor's Choice for May 2016
Prof Gordon McVie - ecancer Founding Editor
Editor's Choice for May 2016 ( Prof Gordon McVie - ecancer Founding Editor )
3 Jun 2016
Oncology for children: what can be done when resources are scarce?
Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi
Oncology for children: what can be done when resources are scarce? ( Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi )
6 May 2016
Relapsed Hodgkin lymphoma in PET positive patients
Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016
A presurgery combination therapy may improve outcomes for women with Her2...
Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania...
A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )
6 May 2016
Integrating multiple omics information in the era of precision oncology
Dr Yu Shyr - Vanderbilt-Ingram Cancer Center, Nashville, USA
Integrating multiple omics information in the era of precision oncology ( Dr Yu Shyr - Vanderbilt-Ingram Cancer Center, Nashville, USA )
5 May 2016
'Helper' T Cells effective in therapy, and shows early clinical responses in...
Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA
'Helper' T Cells effective in therapy, and shows early clinical responses in patients with metastatic cancer ( Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA )
4 May 2016
The role of the microenvironment and novel therapies in CLL
Prof Jan Burger - MD Anderson Cancer Center, Texas, USA
The role of the microenvironment and novel therapies in CLL ( Prof Jan Burger - MD Anderson Cancer Center, Texas, USA )
29 Apr 2016
p62: Metabolism and the tumour microenvironment
Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La...
p62: Metabolism and the tumour microenvironment ( Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA )
29 Apr 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation